|

Aminohippurate Sodium Inj 20% Clinical Trials

1 actively recruiting trial across 1 location

-1 trial since June 2026

Also known as: -Sodium 4-amino hippurate (PAH) inj 20% 2g/10mL -Para-aminohippurate, Aminohippuric acid, Para-aminohippurate, Sodium 4-amino hippurate (PAH) inj 20% 2g/10mL

Top Sponsors

  • Petter Bjornstad1

Indications

  • Adolescent Obesity1
  • Kidney Hypoxia1
  • Diabetic Kidney Disease1
  • Pre Diabetes1
  • Puberty1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.